Shaharyar Khan, PhD, Chief Scientific Officer Number Of Employees: ~27 Stage: Private, Series B2 Financial Snapshot: Has raised $224M total across funding rounds, including a $132M Series B Notable Investors: RA Capital Management
Published Research Data Quantified findings from peer-reviewed studies on CJC-1295 amino acid residues in the CJC-1295 peptide sequence HPLC-verified purity range across published batch testing Published Research Studies on CJC-1295 2008 Growth hormone-releasing hormone analogues: chemistry and pharmacology Endocrine 2006 Prolonged stimulation of growth hormone secretion by CJC-1295 J Clin Endocrinol Metab Clinical study demonstrating CJC-1295's ability to produce sustained, dose-dependent increases in growth hormone and IGF-1 levels
Visit the pharmacy's website for more prescribing details if needed
At the same time, GLP-1 therapies are generally prescribed as part of a broader health plan, which may include nutrition and physical activity guidance from a healthcare professional
GHK-Cu is frequently studied for its ability to enlarge hair follicles, stimulate structural proliferation of follicular epithelial cells, and suppress pro-apoptotic pathways that drive premature follicle regression
Some individuals may feel a mild stinging or burning sensation during or immediately after the injection, but this typically fades within minutes